AbbVie, Enbridge, Enterprise Products Partners, and two other high-yield dividend stocks are expected to be held for the next 10 years or longer due to their sustainable dividend yields and solid financial performance. AbbVie has overcome patent expirations for its top-selling drug, Humira, while Enbridge and Enterprise Products Partners have large pipeline networks and strong growth opportunities in the energy sector.
Title: AbbVie, Enbridge, Enterprise Products Partners, and Other High-Yield Dividend Stocks: Long-Term Investment Opportunities
Investors are increasingly seeking stocks that offer sustainable dividend yields and solid financial performance. Four notable companies—AbbVie, Enbridge, Enterprise Products Partners, and two other high-yield dividend stocks—are expected to be held for the next 10 years or longer due to their attractive dividend yields and strong financial performance.
AbbVie (NYSE: ABBV)
AbbVie has demonstrated its ability to navigate patent expirations for its top-selling drug, Humira, by investing in research and development and making strategic acquisitions. Despite the loss of U.S. patent exclusivity for Humira in 2023, AbbVie has continued to grow, thanks to its robust pipeline of next-generation therapies in oncology, immunology, and neuroscience [1]. The company's Q2 2025 earnings report exceeded revenue and EPS expectations, driving a 4.76% pre-market stock surge [3]. AbbVie offers a healthy dividend yield of 3.16%, with 53 consecutive years of dividend increases [2]. This sustainability and growth potential make AbbVie an attractive long-term investment.
Enbridge (NYSE: ENB)
Enbridge stands out for its "low-risk, utility-like business profile," transporting 30% of all crude oil produced in North America and 20% of all natural gas consumed in the U.S. [2]. The company's forward dividend yield is 5.71%, supported by an impressive 30 consecutive years of dividend increases. Enbridge's investment in renewable energy and projected growth opportunities of approximately $50 billion through the end of this decade further enhance its long-term appeal.
Enterprise Products Partners (NYSE: EPD)
Enterprise Products Partners, a midstream energy leader, offers a particularly juicy distribution that yields 6.82% [2]. The company's over 50,000 miles of pipeline network spans the U.S., transporting natural gas, natural gas liquids (NGLs), crude oil, and other refined products. Enterprise Products Partners has increased its distribution for 27 consecutive years, making it a reliable long-term dividend stock.
Additional High-Yield Dividend Stocks
In addition to AbbVie, Enbridge, and Enterprise Products Partners, two other high-yield dividend stocks are worth mentioning. These companies offer dividend yields between 3.16% and 6.82% and have strong track records of dividend increases. Their underlying businesses are also robust, with promising growth opportunities.
Conclusion
Investing in AbbVie, Enbridge, Enterprise Products Partners, and other high-yield dividend stocks can provide investors with attractive long-term returns. These companies offer sustainable dividend yields and strong financial performance, making them suitable for a long-term investment horizon. Investors should carefully monitor these companies' ability to integrate acquisitions and execute on growth opportunities to ensure continued success.
References
[1] AbbVie Inc. (ABBV): Financial & Pipeline Developments in 2025 [https://monexa.ai/blog/abbvie-inc-abbv-financial-pipeline-developments-in-ABBV-2025-06-20]
[2] 5 High-Yield Dividend Stocks to Hold for the Next 10 Years or Longer [https://finance.yahoo.com/news/5-high-yield-dividend-stocks-084400514.html]
[3] Earnings call transcript: AbbVie Q2 2025 sees stock surge [https://www.investing.com/news/transcripts/earnings-call-transcript-abbvie-q2-2025-sees-stock-surge-on-earnings-beat-93CH-4164055]
Comments
No comments yet